How do your donations accelerate research for a cure and improve the lives of people affected by MS?
Your generosity supports ACP’s initiatives to accelerate MS research for quicker diagnosis, more effective treatments, and a cure for all living with the disease.
This month, we’re highlighting how your generosity enables the iConquerMS network to execute on research that matters most to people with MS.
People affected by MS have many unanswered questions about how to treat and manage the disease, and how to improve their health and well-being. The COVID-19 pandemic raised even more questions for people living with MS around their risks related to the disease, vaccine safety and efficacy, and many other topics.
Thanks to your support, the iConquerMS network was poised and ready to facilitate the research needed to answer these questions.
The COVER-MS study provided important information about the safety of COVID-19 vaccination in people with MS. A COVER-MS sub-study is exploring vaccination efficacy by studying antibody levels. We’re also developing new surveys and planning new analyses to explore other COVID-related topics, including long COVID, access to Evusheld (COVID-19 preventive therapy), breakthrough COVID infections, and the impact of COVID-19 vaccines on MS symptoms.
By launching and conducting research studies quickly and effectively, focusing the research on the topics that matter most to people living with MS, and making the studies available to the 8,500 (and growing!) members of iConquerMS, the network is making a positive impact on the health and quality of life for people affected by MS. We’re just getting started, too!
